ReEBOV Antigen Rapid Test kit for point-of-care and laboratory-based testing for Ebola virus disease: a field validation study
M. Jana Broadhurst(Partners In Health), Nira R. Pollock(Boston Children's Hospital), Tim Brooks, Santigi Kanu(University of Sierra Leone), Susan Hula(Public Health England), Quy Ton(Partners In Health), Alhaji B Sankoh(University of Sierra Leone), Nicholas Sarchet(Partners In Health), Elisabetta Groppelli(University of Sierra Leone), J. Daniel Kelly(University of California, San Francisco), Andrew J. H. Simpson(University of Hull), Mark D. Perkins(Louisiana State University Health Sciences Center Shreveport), Ann C. Miller(Partners In Health), Daniel P. Bailey(Public Health England), Betsy Wonderly(FIND), Peter George(University of Sierra Leone), Alhaji Jalloh(University of Sierra Leone), Amanda Semper(UK Health Security Agency), Wilfred Nyoni(Public Health England), Megan Murray(Harvard Global Health Institute)
Cited by 205
Related Papers
Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison
|The Lancet Infectious Diseases|2020|405
Detection of Zika Virus in Semen
|Emerging infectious diseases|2016|363
Long COVID manifests with T cell dysregulation, inflammation and an uncoordinated adaptive immune response to SARS-CoV-2
|Nature Immunology|2024|338
Markers of Immune Activation and Inflammation in Individuals With Postacute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 Infection
|The Journal of Infectious Diseases|2021|332
SARS-CoV-2 Variants of Interest and Concern naming scheme conducive for global discourse
|Nature Microbiology|2021|315